"The U.S. Food and Drug Administration today approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older. Nucala is approved for patients who have a history of "...
(theophylline) Tablets USP
Theophylline is structurally classified as a methylxanthine. It occurs as a white, odorless, crystalline powder with a bitter taste. Anhydrous theophylline has the chemical name 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, and is represented by the following structural formula:
The molecular formula of anhydrous theophylline is C7H8N4O2 with a molecular weight of 180.17. THEOLAIR Tablets contain 125 mg or 250 mg of theophylline anhydrous intended for oral administration. THEOLAIR (theophylline tablets) Tablets also contain: colloidal silicon dioxide, lactose, magnesium stearate, and pregelatinized starch.
Last reviewed on RxList: 4/7/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Theolair Information
- Theolair Drug Interactions Center: theophylline oral
- Theolair Side Effects Center
- Theolair FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
Allergies & Asthma
Improve treatments & prevent attacks.